We believe that early, accurate diagnosis is better than waiting for problems to arise, and a pro-active approach greatly benefits people’s health, identifies issues early in their development, prevents accidents from happening and has a positive effect on performance, productivity and reputation.

The POC testing market is set to reach $49 billion by 2020 and is growing in all major segments: hospitals, ambulatory care settings, physician offices and home care. The market is forecasted to grow at a 10.9% average annual growth rate.

We are a science- and quality-focused company with the goal of providing innovative Point of Care and In Vitro Diagnostics technology to medical and health care professionals. Our team members and our partners are devoted researchers with an impressive track record, and they address upcoming clinical and economic needs through applied research and innovative technology.




Office Europe:
Life Science Business
Flight Forum 40
5657 DB Eindhoven
The Netherlands

Contact information:
E: info@lifesciencebusiness.nl

Tel.: 0031-(0)40 - 7983021

Office The Middle East :
Life Science Business
P. O. Box: 122022